Anondita Medicare Ltd IPO

Anondita Medicare Ltd IPO

Miscellaneous

sme

Bidding period

22 Aug 2025 - 26 Aug 2025

Bid price

₹137.00 - ₹145.00

Listing on

NSE-SME

Listing date

01 Sep 2025

Lot size

1000 shares

Issue size

₹69.50 crore


Minimum investment

₹2,90,000.00 / 2 lot

Maximum investment

₹2,90,000.00 / 2 lot

Bidding closed on 26 Aug 2025

Open Demat Account
Open Demat Account

Pre-issue Post-issue
Promoter group 83.95 61.71
Public group 16.05 38.29

Information currently unavailable

  • Production capabilities.

  • Experienced management team and a motivated and efficient work force.

  • Cordial relations with our consumers.

  • Quality assurance and control.

  • The Company had negative cash flows from its operating, investing and financing activities in the past and may continue to have negative cash flows in the future. Sustained negative cash flow could impact the company growth and business.

  • The company depends on its top 10 customers for a significant portion of the company revenues. The loss of a major customer or significant reduction in demand from any of its major customers may adversely affect the company business, financial condition, results of operations and prospects.

  • The Company derives a significant portion of its revenue from government contracts and tenders for the supply of condoms under various public health initiatives. Participation in these tenders is subject to stringent regulatory compliance, quality standards, and other eligibility criteria. Any failures to meet the requirements enlisted in these tenders may result in the Company being debarred or disqualified from participating in future government tenders, which could have a material adverse effect on the company business, financial condition, and results of operations.

  • The company had obtained secured loans amounting to Rs. 2715.37 lakhs and unsecured loans amounting to Rs. 23.73 lakhs on a consolidated basis until March 31st 2025. As such any fluctuation in interest rates or change in repayment plan may adversely affect the Company's business. Moreover, unsecured loans could be recalled by Its lenders at any time, which may be earlier than anticipated, affecting the company repayment schedule.

  • Majority of assets, including both movable and immovable, have not yet been transferred under the name of the company.

  • The company Subsidiary, Anondita Healthcare and Rubber Products (India) Limited, have incurred losses in the past and may continue to do so in the future. Its may be required to fund the operations of the company Subsidiary in the future and Its investments in the company Subsidiary may eventually be written off, which could subject it to additional liabilities and could have an adverse effect on the Company's reputation, profitability and financial condition.

  • There is outstanding litigation pending against the company which, if determined adversely, could affect its business, results of operations and financial condition.

  • The company is dependent on third parties for the distribution and marketing of its products. If the company do not maintain and increase the number of its arrangements for the marketing and distribution of the company products, its business, financial condition and results of operations could be adversely affected.

  • Its top three states contribute its major revenue for the Financial year ended 31st March 2025, March 31st 2024, March 31st 2023. Any loss of business from one or more of these states may adversely affect the company revenues and profitability.

  • The company Registered Office and Corporate Office are shared with its promoter group companies and the same are not owned by it. Any termination of the relevant lease agreement in connection with such properties or its failure to pay annual lease rental, the same could adversely affect the company operations. If the company is required to vacate the same or if the company is unable to renew its current leases, due to any reason whatsoever, it may adversely affect the company business operations.

Maashitla Securities Pvt Ltd

Phone number 011-45121795
E-mail ID ipo@maashitla.com
Website www.maashitla.com

QIB shares offered

9,06,000 (18.9%)

NII (HNI) shares offered

6,81,000 (14.21%)

Retail shares offered

15,84,000 (33.05%)

Anchor investor shares offered

13,52,000 (28.21%)

Total shares offered

47,93,000

Total shares with anchor investor

47,93,000

  • Narnolia Financial Services Ltd

Explore other IPOs

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)